The global gynecological devices market size is expected to reach USD 18.1 billion by 2030, according to a new report by Grand View Research. It is expected to register a CAGR of 8.64% from 2023 to 2030. The rising women population, growing awareness regarding early diagnosis, and available treatments for gynecological disorders are anticipated to boost the growth of the industry. The rising adoption of gynecological procedures is estimated to boost product demand over the forecast period. According to the National Center for Health Statistics, in the U.S., cesarean deliveries accounted for 31.8% of the total deliveries in 2020 when compared with vaginal deliveries. A rise in the number of these procedures, increasing awareness, and growing disposable income are expected to drive the industry.
Early disease detection is imperative in devising treatment schedules. Pertinent government and regulatory agencies in collaboration with the above factors are now focusing majorly on improving patient awareness regarding reproductive and women’s health. This is expected to boost the growth of the industry during the forecast period. Furthermore, the COVID-19 pandemic has adversely affected the industry owing to the cancelation and postponement of elective surgeries, and a reduction of visits of the patients for gynecological surgeries. The demand for gynecological devices increased in the second half of 2020 with the ease of restrictions. The adoption of telehealth and technological advancements is expected to increase product demand during the forecast period.
The surgical devices product segment held the largest revenue share in 2022 due to the recurring purchase of disposable products and the high cost of surgical devices
In 2022, the endoscopy devices segment held the largest revenue share. This is due to the availability of advanced products, such as 3D endoscopes, and the adoption of Artificial Intelligence (AI)
The hospitals & clinics end-user segment dominated the global industry in 2022 owing to the easy access and high volume of gynecological surgeries performed in hospitals & clinics
North America held the largest revenue share in 2022 due to advanced healthcare infrastructure, availability of skilled professionals, and introduction of innovative technologies
Asia Pacific is expected to witness significant growth during the forecast period. A surge in procedure volumes, due to the rising awareness regarding gynecological health, post-menopausal conditions, and issues concerning pregnancy, is expected to drive the region’s growth
Grand View Research has segmented the global gynecological devices market on the basis of product, end-user, and region:
Gynecological Devices Product Outlook (Revenue, USD Million, 2017 - 2030)
Surgical Devices
Gynecological Endoscopy Devices
Hysteroscope
Colposcope
Resectoscope
Laparoscope
Endoscopic Imaging Systems
Endometrial Ablation Devices
Hydrothermal Ablation Devices
Radiofrequency Ablation Devices
Balloon Ablation Devices
Others (Microwave, Laser)
Fluid Management Systems
Female Sterilization/Contraceptive Devices
Permanent Birth Control
Intra Uterine Devices (IUD)
Intravaginal Rings
Subdermal Contraceptive Implants
Handheld Instruments
Vaginal Speculum
Tenaculum
Curettes
Trocars Market
Biopsy Forceps
Others
Diagnostic Imaging Systems
Gynecological Devices End-use Outlook (Revenue, USD Million, 2017 - 2030)
Hospital & Clinics
Ambulatory Surgery Centers (ASCs)
Gynecological Devices Regional Outlook (Revenue, USD Million, 2017 - 2030)
North America
U.S.
Canada
Europe
U.K.
Germany
France
Italy
Spain
Asia Pacific
Japan
China
India
Australia
South Korea
Latin America
Mexico
Brazil
Argentina
Middle East & Africa (MEA)
South Africa
Saudi Arabia
UAE
List of Key Players of Gynecological Devices Market
Medtronic Plc
Cooper Surgical, Inc.
Richard Wolf GmbH
Hologic, Inc.
Boston Scientific Corp.
Stryker Corp.
Karl Storz GmbH & Co. KG
Ethicon, Inc. (Johnson & Johnson MedTech)
Cook Medical
Bayer AG
Gynemed
Gynex Corp.